CRISPR Therapeutics AG
CRSP
29 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Jun 1 9:35 PM | Naimish PatelChief Medical Officer | Sale | 3,786 | $55.62 | $210.6K | 19,357(D) | View → |
| Mar 23, 2026 | Mar 24 9:38 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 3,182 | $46.78 | $148.9K | 94,308(D) | View → |
| Mar 23, 2026 | Mar 24 9:37 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 10,020 | $46.78 | $468.7K | 255,501(D) | View → |
| Mar 23, 2026 | Mar 24 9:37 PM | Raju PrasadChief Financial Officer | Sale | 3,708 | $46.78 | $173.5K | 15,565(D) | View → |
| Mar 16, 2026 | Mar 17 9:37 PM | Naimish PatelChief Medical Officer | Sale | 3,150 | $48.26 | $152.0K | 13,143(D) | View → |
| Mar 16, 2026 | Mar 17 9:37 PM | Raju PrasadChief Financial Officer | Sale | 9,869 | $48.26 | $476.3K | 13,773(D) | View → |
| Mar 16, 2026 | Mar 17 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 3,450 | $48.26 | $166.5K | 91,240(D) | View → |
| Mar 16, 2026 | Mar 17 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 10,349 | $48.26 | $499.4K | 245,834(D) | View → |
| Mar 11, 2026 | Mar 12 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 2,800 | $52.80 | $147.8K | 87,815(D) | View → |
| Mar 11, 2026 | Mar 12 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 9,798 | $52.80 | $517.3K | 235,558(D) | View → |
| Feb 19, 2026 | Feb 20 10:36 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 6,967 | $52.58 | $366.3K | 226,106(D) | View → |
| Feb 19, 2026 | Feb 20 10:35 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 2,112 | $52.58 | $111.0K | 85,115(D) | View → |
| Apr 3, 2025 | Jan 27 10:35 PM | Naimish PatelChief Medical Officer | Purchase | 1,508 | $32.96 | $49.7K | 1,508(D) | View → |
| Jan 22, 2026 | Jan 26 10:35 PM | Raju PrasadChief Financial Officer | Sale | 34,972 | $60.19 | $2.1M | 6,767(D) | View → |
| Jan 22, 2026 | Jan 22 10:55 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 60,000 | $60.23 | $3.6M | 134,201(D) | View → |
| Jan 20, 2026 | Jan 22 10:55 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 30,000 | $51.75 | $1.6M | 194,201(D) | View → |
| Jan 22, 2026 | Jan 22 10:15 PM | Samarth Kulkarni | Proposed Sale | 60,000 | $60.81 | $3.6M | — | View → |
| Jan 22, 2026 | Jan 22 9:03 PM | RAJU PRASAD | Proposed Sale | 34,972 | $60.19 | $2.1M | — | View → |
| Jan 20, 2026 | Jan 20 10:11 PM | Samarth Kulkarni | Proposed Sale | 30,000 | $52.61 | $1.6M | — | View → |
| Jan 6, 2026 | Jan 6 10:11 PM | RAJU PRASAD | Proposed Sale | 29,700 | $60.16 | $1.8M | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 9 10:09 PM | Simeon GeorgeDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 10:06 PM | Ali BehbahaniDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:43 PM | Maria FardisDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:43 PM | Harold Edward FlemingDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:43 PM | John GreeneDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:42 PM | Katherine A HighDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:42 PM | Sandesh MahatmeDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:41 PM | Briggs MorrisonDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:41 PM | Christian RommelDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:40 PM | Douglas A TrecoDirector | Grant/Award | 13,000 | $51.84 | 13,000(D) | View → |
| May 29, 2026 | Jun 2 9:42 PM | James R. KasingerGeneral Counsel and Secretary | Grant/Award | 17,000 | — | 17,000(D) | View → |
| May 29, 2026 | Jun 2 9:41 PM | Naimish PatelChief Medical Officer | Grant/Award | 22,000 | — | 22,000(D) | View → |
| May 29, 2026 | Jun 2 9:41 PM | Raju PrasadChief Financial Officer | Grant/Award | 19,500 | — | 19,500(D) | View → |
| May 28, 2026 | Jun 1 9:35 PM | Naimish PatelChief Medical Officer | Option Exercise | 10,000 | — | 20,000(D) | View → |
| Mar 20, 2026 | Mar 24 9:38 PM | James R. KasingerGeneral Counsel and Secretary | Option Exercise | 6,250 | — | 12,000(D) | View → |
| Mar 20, 2026 | Mar 24 9:38 PM | James R. KasingerGeneral Counsel and Secretary | Grant/Award | 63,499 | $46.24 | 25,000(D) | View → |
| Mar 20, 2026 | Mar 24 9:37 PM | Samarth KulkarniDirector, Chief Executive Officer | Option Exercise | 19,687 | — | 39,375(D) | View → |
| Mar 20, 2026 | Mar 24 9:37 PM | Samarth KulkarniDirector, Chief Executive Officer | Grant/Award | 196,124 | $46.24 | 81,875(D) | View → |
| Mar 20, 2026 | Mar 24 9:37 PM | Raju PrasadChief Financial Officer | Option Exercise | 6,250 | — | 12,500(D) | View → |
| Mar 20, 2026 | Mar 24 9:37 PM | Raju PrasadChief Financial Officer | Grant/Award | 65,999 | $46.24 | 27,500(D) | View → |
Page 1 of 2
Next →